Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.

Ravi A MadanMarijo BilusicMark N SteinRenee N DonahuePhilip M ArlenFatima KarzaiElizabeth PlimackYu-Ning WongDaniel M GeynismanMatthew ZibelmanTina MayerJulius StraussGang ChenMyrna RauckhorstSheri McMahonAnna CouvillonSeth SteinbergWilliam D FiggWilliam L DahutJeffrey SchlomJames L Gulley

Published in: The oncologist (2023)

The combination of flutamide+PROSTVAC did not improve outcomes in men with nmCRPC compared with flutamide alone. (ClinicalTrials.gov Identifier: NCT00450463).

Keyphrases

prostate cancer
squamous cell carcinoma
radical prostatectomy
small cell lung cancer
type diabetes
middle aged
metabolic syndrome
skeletal muscle
insulin resistance
glycemic control